Disclosure 0001701247-26-000013-3

SEC FORM 4

$93,507.21

Enliven Therapeutics, Inc. (ELVN)

Sale of 1,844 shares at $50.7089 per share.

Reporting Person Collins Helen Louise · Officer Title CHIEF MEDICAL OFFICER · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0001701247-26-000013 · filed 2026-09-21 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Enliven Therapeutics, Inc. (ELVN)." Disclosed 2026-09-21. https://desqlong.com/cards/0001701247-26-000013-3 (retrieved 2026-09-26).